Machelle Sanders, Director at Novan, holds 27.74K shares in BioCryst (Ticker: BCRX), holds 25.25K shares in Novan (Ticker: NOVN), holds 0.00 shares in Radius Health (Ticker: ~RDUS). Most recently, Machelle Sanders Sold ― shares of BioCryst on Jun 17, 2024 for an estimated value of 28.13K.
Machelle Sanders latest transaction was an Informative Sell of $28.13K.
What was Machelle Sanders's most profitable transaction?
Machelle Sanders’s most profitable transaction was an Informative Sell of BCRX stock on June 15, 2023. The return on the trade was 22.60%.
What is Machelle Sanders's role in Novan?
Machelle Sanders's role in Novan is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.